Takeda Pharmaceutical Co Ltd (TKPHF) community

TKPHFOTCPharmaceutical PreparationsAlso trades as TAK

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30

$39.00+0.36 (+0.93%)

Close on Oct 19, 2026Market cap $134.41BP/E –Yield –

Community

Notes and questions about Takeda Pharmaceutical from other investors

No posts about TKPHF yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Takeda Pharmaceutical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TKPHF.

Compare: TKPHF vs NVO · TKPHF vs RDY · TKPHF vs AZN · TKPHF vs PFE · TKPHF vs LLY

Revenue growth-1.7% · median 16.2%

Gross margin65.1% · median 78.4%

Net margin-3.4% · median 19.3%

Company	Revenue	Growth
TKPHF	¥4.51T	-1.7%
LLY	$86.46B	+45.5%
PFE	$63.70B	-0.2%
AZN	$29.01B	+16.2%
NVO	–	–
RDY	–	–

Company

Exchange: OTC
Industry: Pharmaceutical Preparations
Employees: 47,000
Auditor: KPMG AZSA LLC
SEC CIK: 1395064

Advertisement
300 × 250